Efficacy and safety of brodalumab in the Korean population for the treatment of moderate to severe plaque psoriasis: A randomized, phase III, double‐blind, placebo‐controlled study...

por Seo, Seong Jun, Shin, Bong Seok, Lee, Joo‐Heung, Jeong, Haeyoun
Publicado 2020

Brodalumab, an anti–interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 study

por Kim, Tae-Hwan, Kishimoto, Mitsumasa, Wei, James Cheng-Chung, Jeong, Haeyoun, Nozaki, Akiyo, Kobayashi, Shigeto
Publicado 2022

Efficacy and safety of brodalumab, an anti-IL17RA monoclonal antibody, in patients with axial spondyloarthritis: 16-week results from a randomised, placebo-controlled, phase 3 tria...

por Wei, James Cheng-Chung, Kim, Tae-Hwan, Kishimoto, Mitsumasa, Ogusu, Naoki, Jeong, Haeyoun, Kobayashi, Shigeto
Publicado 2021